It will also manage test result documentation for employees who are not vaccinated, sending weekly reminders and employer notification
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
At present 18 per cent of the local pharmaceutical market is under government's price control
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
Employees of QubeHealth’s corporate clients draw as much money as they need to instantly pay for any medical emergencies or regular healthcare payments
Subscribe To Our Newsletter & Stay Updated
